Literature DB >> 30294764

Management of Late-Life Depression.

J Craig Nelson1.   

Abstract

Depression is a common disorder in late life that is associated with poor quality of life, increased disability, and increased all-cause mortality. Rates of completed suicide are the highest in older depressed men compared with any other age group. In this age group, depression is often concurrent with medical illness and it can aggravate the course of medical illness. Cognitive impairment is frequently present and may be the result of the depression itself or may be the consequence of a neurodegenerative disorder such as Alzheimer's disease. Evidence-based psychotherapies, antidepressants, and somatic treatments such as electroconvulsive therapy are employed in the treatment of older depressed adults. Treatment may be complicated by the presence of cognitive impairment, other comorbid medical disorders, and medications used to treat these disorders. Certain safety issues such as increased bleeding risk, hyponatremia, decreased bone density and falls may be associated with antidepressant treatment, may be more common in older depressed adults, and their consequences may be more severe in late life. These risks, however, need to be weighed against the hazards of untreated depression. With appropriate care, most older depressed patients can be successfully treated and a positive outcome can have a significant effect on the patient's quality of life.

Entities:  

Keywords:  Depression; Geriatric; Late life

Mesh:

Substances:

Year:  2019        PMID: 30294764     DOI: 10.1007/164_2018_170

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  2 in total

1.  Predictors of CNS-Active Medication Use and Polypharmacy Among Homebound Older Adults With Depression.

Authors:  Namkee G Choi; C Nathan Marti; Mark E Kunik
Journal:  Psychiatr Serv       Date:  2020-04-28       Impact factor: 3.084

2.  [Correlation between suicidal ideation and polysomnography parameters in late-life depression patients].

Authors:  Liqiang Cai; Yafeng You; Lili Wei; Yanhua Qin; Jiashu Yao; Yi Sun; Lisan Zhang; Wei Chen
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.